Older and New Formulations of Cladribine. Pharmacology and Clinical Efficacy in Hematological Malignancies
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
1
Page:
23-38
Author(s):
Tadeusz Robak, Anna Korycka and Ewa Robak
Patent Annotations
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
1
Page:
135-140
Author(s):
Bentham Science Publishers
Current Status and Future of Antifungal Therapy for Systemic Mycoses
Journal:
Recent Patents on Anti-Infective Drug Discovery
Volume:
1
Page:
75-84
Author(s):
Joshua D. Nosanchuk
New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
327-340
Author(s):
Niels W.C.J. van de Donk, Andries C. Bloem, Ellen v. d. Spek and Henk M. Lokhorst
VEGF Inhibitors in Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
387-394
Author(s):
Adela R. Cardones and Lionel L. Banez
Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders
Journal:
Reviews on Recent Clinical Trials
Volume:
1
Page:
15-34
Author(s):
Tadeusz Robak, Agnieszka Wierzbowska and Ewa Robak
Systemic Fungal Infections Caused by Aspergillus Species: Epidemiology, Infection Process and Virulence Determinants
Journal:
Current Drug Targets
Volume:
6
Page:
875-886
Author(s):
Axel A. Brakhage
Rasburicase: A New Approach for Preventing and/or Treating Tumor Lysis Syndrome
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
4177-4185
Author(s):
Olga Bessmertny, Lauren M. Robitaille and Mitchell S. Cairo
Prospects and Limitations of T Cell Receptor Gene Therapy
Journal:
Current Gene Therapy
Volume:
5
Page:
583-593
Author(s):
Miriam Coccoris, Moniek A. de Witte and Ton. N.M. Schumacher
Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
573-578
Author(s):
Domenico Ribatti and Angelo Vacca